The VariantBaits™ system is a target enrichment strategy based on liquid phase hybridization, using biotin-labeled probe baits. Designed for coverage of known coding regions, the VariantBaits™ Standard Panels offer cost-effective, ultra-high resolution sequence analysis for revealing clinically relevant mutations.
The VariantBaits Tumor 500 Gene Capture Kit is powered by more than 30,160 oligos synthesized on LC Sciences patented μParaflo® microfluidic arrays.
The RNA probe consisted of a total capture target area of 1.73 Mb. A total of 512 tumor-related gene exons were detected in the kit, covering MSK products.
All TMB-related genes, including MSI sites, targeted drug genes, chemotherapy genes, amplified genes, diagnostic genes, prognostic genes, genetics
Genes, driving genes, etc. Fusion detection contains a common fusion type of 15 genes.
|Panel||No. of Samples||Catalog No.|
|VariantBaits™ Oncology 500 Kit||24||VBK1902-24|
|VariantBaits™ Oncology 500 Kit||96||VBK1902-96|
|VariantBaits™ Oncology 500 Kit||384||VBK1902-384|